
Arkia Labs helps researchers and biotech companies speed up AI-driven genome editing projects. It provides a platform that combines AI workflows with genome editing tooling to streamline research and development. The offering targets B2B customers such as biotech firms, pharma labs, and academic labs seeking faster exploration and deployment. The core tech includes AI models, computational biology capabilities, and genome editing tools integrated into cloud-based workflows. The company positions itself to scale across the life sciences market by enabling faster innovation and collaboration.

Arkia Labs helps researchers and biotech companies speed up AI-driven genome editing projects. It provides a platform that combines AI workflows with genome editing tooling to streamline research and development. The offering targets B2B customers such as biotech firms, pharma labs, and academic labs seeking faster exploration and deployment. The core tech includes AI models, computational biology capabilities, and genome editing tools integrated into cloud-based workflows. The company positions itself to scale across the life sciences market by enabling faster innovation and collaboration.